Reconsidering Dexmedetomidine for Sedation in the Critically Ill: Implications of the SPICE III Trial
Annals of Pharmacotherapy - United States
doi 10.1177/1060028019890672
Full Text
Open PDFAbstract
Available in full text
Date
November 19, 2019
Authors
Publisher
SAGE Publications